Put 10% tariff on all trade profits and fund research.😅 🇮🇳 #ScienceFirst #InnovationIndia #DeepTechIndia @Zoho @Banerjeesv @svembu @sabakaul1 @AdityaRajKaul @NSO365 @JaipurDialogues @ajeetbharti @ARanganathan72 @nsitharamanoffc @Rashtra_Sevika_ @SEBI_India @drgunjand

“India needs advanced scientific research and a scientific temperament — that’s the only path to global leadership.” ✨🇮🇳 #ScienceFirst #InnovationIndia #FutureBuilders #DeepTechIndia

“India needs advanced scientific research and a scientific temperament — that’s the only path to global leadership.” ✨🇮🇳 #ScienceFirst #InnovationIndia #FutureBuilders #DeepTechIndia

“India needs advanced scientific research and a scientific temperament — that’s the only path to global leadership.” ✨🇮🇳 #ScienceFirst #InnovationIndia #FutureBuilders #DeepTechIndia

“India needs advanced scientific research and a scientific temperament — that’s the only path to global leadership.” ✨🇮🇳 #ScienceFirst #InnovationIndia #FutureBuilders #DeepTechIndia

माननीय @DrSatishPoonia जी, “खेजड़ी पौधारोपण” पर्यावरण दिवस पर आयोजन सराहनीय है। लेकिन सवाल उठता है क्या मरुभूमि राजस्थान में 5 जून वास्तव में वृक्षारोपण के लिए सबसे उपयुक्त समय है? राजस्थान की पर्यावरणीय परंपरा हमें याद दिलाती है कि इस समय प्राथमिकता पेड़ नहीं, पानी रहा है। सदियों से इस अवधि में तालाबों की गाद निकालना, जोहड़ों की मरम्मत और जलस्रोतों को वर्षा के लिए तैयार करना ही असली “पर्यावरण कार्य” माना गया है। पेड़ लगाने का वैज्ञानिक रूप से उपयुक्त समय बरसात के बाद होता है, ताकि पौधे जीवित रह सकें और केवल प्रतीक न बनें। प्रधानमंत्री @narendramodi जी का “एक पेड़ माँ के नाम” अभियान प्रेरणादायक है, पर स्थायी हरियाली तभी संभव है जब परंपरा विज्ञान साथ चलें। खेजड़ी हमारी मरुधरा की पहचान है इसे प्रतीक नहीं, जीवंत रखना होगा। राजस्थान की परम्परा कहती है- “तालाब भरे बिना पेड़ नहीं बचते।” #Rajasthan #WorldEnvironmentDay #WaterFirst #Khajri #EcoAwareness #ScienceFirst

Highly irresponsible framing. Calling this “Covid 2.0” before verified epidemiological context is exactly how panic spreads faster than pathogens. Hantavirus ≠ Covid. Transmission dynamics, vectors, risk profiles, and public health implications are different. Serious health events need: ✅ facts ✅ lab confirmation ✅ transparent health authority guidance —not viral fear marketing. Public communication during outbreaks should inform, not sensationalize. Fear is contagious too. 🦠⚠️ #PublicHealth #Hantavirus #HealthCommunication #FactCheck #ScienceFirst

THE WELLNESS INDUSTRY HATES THIS.😤 Read the full interview here: medium.com/authority-magazin… We didn't ask for permission. We built a lab in our home 🧪, put our careers on hold, and reverse-engineered a way out of the medical maze for a loved one. When the system offered symptom management, we wanted health back. That is not the typical origin story of a brand. Most companies find a hot ingredient, slap a label on it, and outsource everything. We saw that and thought: This is completely backwards. 🔄 So we did five things that "smart" business people told us never to do: 1. We started with the extreme case, not the mass market (ME/CFS, fibromyalgia, POTS – the ones everyone else gave up on). 🧠 2. We followed the peer-reviewed science, not the shelf in CVS. 📚 3. We kept the brain in-house – every formula, every test, every adjustment. No white labels. No outsourced R&D. 🔬 4. We priced for the customer we wanted – the one who invests in a result, not the one fighting over $8 toothpaste. 💎 5. And we were willing to burn our own boats (yes, including renaming the entire company after a legal fiasco over the word "Milk"). 🔥 @AuthorityMgzine (published on @Medium) just sat down with us to talk about how we are shaking up a stagnant industry. The interview covers the real story: the autoimmune diagnosis that started it all, why OralMiracle is not a toothpaste, and the data-driven future of personalized wellness. If you are tired of watered-down products and marketing hype, you will want to read this. 👇 Read the full interview here: medium.com/authority-magazin… #immunizeLABS #Disruptors #WellnessThatWorks #chronicillness #OralMiracle #ScienceFirst

Hey everyone, Important reminder for everyone following along: All of my blog posts, X posts, threads, comments, and discussions are strictly for research and educational purposes only. Even when certain posts explore or mention human use scenarios, dosages, or outcomes, it is purely theoretical and hypothetical. The content is shared to spark curiosity and understanding of the scientific literature — it only carries more grounded real-world context when I directly cite specific peer-reviewed studies. And even then, it’s solely for informational awareness. Nothing I share here is intended, approved, recommended, or safe for human consumption, self-experimentation, or any practical/personal application. These are complex compounds and topics — always consult qualified healthcare professionals and do your own due diligence before considering anything related to your health. Thanks for being part of this journey. Stay curious, stay safe, and keep elevating responsibly! #EducationOnly #ScienceFirst #Biohacking #ResearchOnly #EducationOnly

U.S. rescheduling of certain cannabinoid-based products signals continued progress toward integrating cannabinoid therapeutics into a regulated, evidence-driven framework. Avicanna remains focused on clinical development, scientific innovation, and responsible pathways to future market participation. Full Release and scientific update below 👇 avicanna.com/avicanna-welcom… #AvicannaAdvantage #ScienceFirst #HowWeWork #USA

The most appropriate approach is to return to medical reports, not to rely on political narratives or social biases. #EvidenceBased #MedicalTruth #StayObjective #ScienceFirst

𝐈𝐧𝐝𝐢𝐚'𝐬 𝐬𝐤𝐢𝐧𝐜𝐚𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐟𝐮𝐥𝐥 𝐨𝐟 𝐩𝐫𝐨𝐦𝐢𝐬𝐞𝐬. 𝐁𝐞 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐢𝐬 𝐛𝐮𝐢𝐥𝐭 𝐨𝐧 𝐩𝐫𝐨𝐨𝐟. Hemangi Dhir didn't find a gap through market research — she experienced it as a consumer. No brand was building clinically validated, in-vivo tested skincare specifically for Indian skin's unique response to ageing, UV exposure, and pollution. So she built one herself. From scratch. With in-house R&D, manufacturing, and quality control all under one roof. This is what happens when a founder lives the problem and refuses shortcuts. Proud to share #BeClinical's story as part of our Emerging Titans series. 🔬 #BeClinical #IndianSkincare #EvidenceLed #EmergingTitans #TitanCapital #D2C #FounderStory #ScienceFirst

After years of surgeries, rehab and a recovery machine built for return-to-play, former NBA forward, @violajefe Al Harrington, stopped asking whether cannabis could help and started asking harder questions about how it actually worked. The cannabis wellness boom gave us plenty of sleek bottles, soft-focus promises and celebrity-backed products that seemed designed to sell a mood more than solve a problem. Harrington, by his own account, started moving in the opposite direction. “That shift happened when I started talking to people who were actually doing serious work in the space,” he said, describing when he stopped treating #CBD as a trend and started caring about the mechanics behind it. “Hearing about #clinical trials and seeing real data made me realize it was more than just a trend. Then connecting with Avicanna opened my eyes to the level of innovation happening with formulations and delivery systems. That was a game changer for me.....that made it easier to really dive into the research and understand what was happening beyond just personal experience.” Hear more from the pro in HIGH TIMES 👇 hightimes.com/sports/the-nba… $AVCN #AvicannaInside #ScienceFirst #HowWeWork #RecoverLikeAPro #Replay

Extrapolating results from lab dishes or animal studies to human patients is dangerous. Cancer is incredibly complex, and there is zero clinical evidence from large-scale human trials to suggest it treats 20 types of cancer or just any. ​Choosing unproven cures over validated oncology care can be fatal. ​Science moves forward through rigorous trials, not viral anecdotes. Stick to evidence based medicine! 🔬🧪 #Oncology #MedicalFacts #Fenbendazole #ScienceFirst #Healthtuner

Proud to support this important clinical research with the University of Calgary, helping to better define dose-response relationships and the therapeutic window of oral THC through controlled, evidence-driven study design. At Avicanna, our focus remains clear: generating high-quality clinical data, supporting healthcare professionals, and contributing to a more precise, responsible approach to cannabinoid therapeutics. This is how medical cannabis moves forward: through research, collaboration, and evidence. #AvicannaAdvantage #ScienceFirst #Research #MedicalCannabis

Our Equity Crowd Funding Raise is now live. Today marks the beginning of Cytonics’ next phase. This moment isn’t about hype. It’s about execution. Over the past several years, we’ve focused on strengthening our scientific foundation, refining our clinical strategy, and building the infrastructure needed to move responsibly into what comes next. In our previous Phase 1 clinical study, CYT-108 successfully demonstrated a strong safety profile - an important milestone that allows us to move forward with confidence into the next stage of development. Now, we’re advancing our Phase 1b/2a osteoarthritis clinical study, expanding into oncology, and continuing to develop our analytical and AI capabilities to support smarter, more disciplined decision-making. This phase reflects alignment between the science, the strategy, and the community that believes in what we’re building. Over 7,000 investors have already committed more than $25 million to this mission. You can now be part of what comes next. Visit invest.cytonics.com to learn more and to invest. #biotech #lifescience #clinicaltrials #healthinnovation #drugdevelopment #sciencefirst #patientfocused REG CF Disclaimer: In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. Cytonics has filed a Form C with the Securities and Exchange Commission in connection with its offering, a copy of which may be obtained here: sec.gov/Archives/edgar/data/…

The EU is about to drop its "independent" report on nicotine, and it's a stitch-up. 🏛️💶 1. Ignore consumer feedback? Check. ✅ 2. Use "crony" NGOs for research? Check. ✅ 3. Lie about heart risks? Check. ✅ Don't let Brussels win the media cycle with junk science. 🧪🛑 #NoVapeBan #ScienceFirst #EU2026 clearingtheair.eu/en/post/an…

Is "switching" a lie in some health studies? 📉🤥 New analysis by Dr. @ArielleSelya reveals that recent papers labeled people as "vape switchers" even if they were still smoking. By lumping dual users with complete switchers, researchers are muddying the water on how much vapes actually help. 🧪🚫 #ScienceFirst #VapeFacts #HarmReduction clearingtheair.eu/post/flawe…

63% of smokers are getting the science wrong. 📉🛑 A massive new U.S. study shows most people believe nicotine is the main health threat. Misunderstanding the risk is the biggest barrier to quitting. 🚭🧠 #NicotineFacts #ScienceFirst #HarmReduction clearingtheair.eu/post/most-…